Identification of a Potent and Selective ELOVL6 Inhibitor: Characterization and Application as a Pharmacological Tool

被引：0
|
作者：
Tokita, Shigeru
Shimamura, Ken
Miyamoto, Yasuhisa
Ki-Tazawa, Hidefumi
Nagumo, Akira
Yoshimoto, Ryo
Aragane, Katsumi
Takahashi, Toshi-Yuki
Mizutani, Takashi
Nagase, Tsuyoshi
Sato, Nagaaki
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A362 / A362
页数：1
相关论文
共 50 条
  • [21] BIOCHEMICAL AND PHARMACOLOGICAL ACTIVITIES OF SR 26831, A POTENT AND SELECTIVE ELASTASE INHIBITOR
    HERBERT, JM
    FREHEL, D
    ROSSO, MP
    SEBAN, E
    CASTET, C
    PEPIN, O
    MAFFRAND, JP
    LEFUR, G
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 260 (02): : 809 - 816
  • [22] Pharmacological profile of MEN 11066, a novel potent and selective aromatase inhibitor
    Muratori, A
    Lippi, A
    Mancina, R
    Iafrate, EM
    Cirillo, R
    Lopez, G
    Bigioni, M
    Maggi, A
    Criscuoli, M
    Maggi, CA
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 84 (05): : 503 - 512
  • [23] Identification of ACY-1083: A novel, potent, and highly selective HDAC6 inhibitor
    Molina, Audrey
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [24] Characterization of a potent and selective inhibitor of soluble epoxide hydrolase
    Morita, K
    Ishimoto, T
    Iwahashi, Y
    Sato, M
    Fujikawa, N
    Hirano, H
    Ota, T
    Muramatsu, M
    Miyata, N
    FASEB JOURNAL, 2006, 20 (04): : A668 - A668
  • [25] Identification and characterization of a potent and selective HUNK inhibitor for treatment of HER2+breast cancer
    Dilday, Tinslee
    Abt, Melissa
    Ramos-Solis, Nicole
    Dayal, Neetu
    Larocque, Elizabeth
    Oblak, Adrian L.
    Sintim, Herman O.
    Yeh, Elizabeth S.
    CELL CHEMICAL BIOLOGY, 2024, 31 (05) : 989 - 999.e7
  • [26] Pharmacological characterization of the selective, orally bioavailable, potent mTORC1/2 inhibitor PQR620
    Beaufils, Florent
    Rageot, Denise
    Melone, Anna
    Sele, Alexander
    Lang, Marc
    Mestan, Juergen
    Ettlin, Robert A.
    Hillmann, Petra
    Cmiljanovic, Vladimir
    Walter, Carolin
    Singer, Elisabeth
    Nguyen, Hoa H. P.
    Hebeisen, Paul
    Fabbro, Dorian
    Wymann, Matthias P.
    CANCER RESEARCH, 2016, 76
  • [27] BIOLOGICAL AND PHARMACOLOGICAL CHARACTERIZATION OF AC014081: A SELECTIVE AND HIGHLY POTENT PAN-AURORA KINASE INHIBITOR
    Liu, G.
    Abraham, S.
    Holladay, M.
    Bhagwat, S.
    Hua, H.
    Pulido, J. Ford
    Gunawardane, R.
    Cramer, M.
    Gitnick, D.
    James, J.
    Dao, A.
    Belli, B.
    Armstrong, R. C.
    Breider, M.
    Treiber, D.
    ANNALS OF ONCOLOGY, 2010, 21 : 34 - 34
  • [28] NNC-711, A NOVEL POTENT AND SELECTIVE GAMMA-AMINOBUTYRIC-ACID UPTAKE INHIBITOR - PHARMACOLOGICAL CHARACTERIZATION
    SUZDAK, PD
    FREDERIKSEN, K
    ANDERSEN, KE
    SORENSEN, PO
    KNUTSEN, LJS
    NIELSEN, EB
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 224 (2-3) : 189 - 198
  • [29] BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION OF ICI 186,756 - A NOVEL, POTENT, AND SELECTIVE INHIBITOR OF HUMAN NEUTROPHIL ELASTASE
    WILLIAMS, JC
    STEIN, RL
    STRIMPLER, AM
    REAVES, B
    KRELL, RD
    EXPERIMENTAL LUNG RESEARCH, 1991, 17 (04) : 725 - 741
  • [30] Pharmacological characterization of a novel potent, selective, and orally active phosphodiesterase 2A inhibitor, PDM-631
    Maehara, Shunsuke
    Arakawa, Keita
    Hoshida, Kotaro
    Nagasue, Hiroshi
    Chida, Noboru
    Nakao, Kazunari
    Furusako, Shoji
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 811 : 110 - 116
12345